KIMBERLY FRIESEMA: Open Payments
NPI 1275924755 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 53 payments from 8 companies in 2025. Trend: 2023 $377 · 2024 $2,079 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $414 |
| Amgen Inc. | 14 | $268 |
| Esperion Therapeutics, Inc. | 16 | $248 |
| Novo Nordisk Inc | 4 | $100 |
| HEARTFLOW, INC. | 3 | $84 |
| Chiesi USA, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: LEQVIO, Repatha, NEXLETOL, FFRct, Wegovy, JUXTAPID, ENTRESTO, Ozempic.
Industry payments across NC — which companies pay providers there.
